TAG:
lab managers
Well-Funded Buyers Put Hospital Labs in Bull’s-Eye
By Robert Michel | From the Volume XIX No. 9 – June 25, 2012 Issue
CEO SUMMARY: In less than 12 months, two big private equity firms have each launched a lab company with the goal of acquiring and/or managing the clinical labs of hospitals and health systems. In the case of aLabs, it has signed one laboratory management services contract with Aurora and …
Hospital and Health System Labs Brace for Change
By R. Lewis Dark | From the Volume XIX No. 9 – June 25, 2012 Issue
BY THE TIME MOST OF YOU ARE READING THIS, it is likely that the Supreme Court ruling on the challenge to the Accountable Care Act (ACA) will be public knowledge. It was this week of June 25-June 29 that the ruling was expected to be announced. Obviously, there are three potential rulings: 1) to all…
Health Insurers Now Finding Ways to Cut Costs and Shed Risks
By Robert Michel | From the Volume XIX No. 8 – June 4, 2012 Issue
CEO SUMMARY: Both employers and health insurers are taking aggressive steps to rein in healthcare costs. Several strategies to control spending and create powerful new incentives for providers are gaining favor. At this year’s Executive War College, Paul Mango of McKinsey & Company,…
2011’s Top 10 Lab Stories Point to a Busy 2012
By Robert Michel | From the Volume XIX No. 1 – January 9, 2012 Issue
CEO SUMMARY: Given the specific news stories that make up THE DARK REPORT’S list of the “Top Ten Lab Stories for 2011,” it might be said that 2011 was a rather quiet year overshadowed by anticipation of the coming reforms mandated by the Accountable Care Act of 2010. For the clinica…
Are Prosecutors Afraid of Big and Little Lab Firms?
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: Settlements in the big whistleblower suits involving major lab companies typically generate national headlines. But seldom do the views of the “quiet majority” of lab owners and lab executives get much attention. These are the majority of lab professionals workin…
Understanding the Deal With Medi-Cal and Quest
By Robert Michel | From the Volume XVIII No. 8 – June 13, 2011 Issue
CEO SUMMARY: It is now possible to see the specific language in the “Settlement Agreement and Release” document executed by the California State Attorney General and Quest Diagnostics Incorporated. For those clinical lab managers—and the attorneys who represent their labora…
WellSpan’s Lab Designs the “Ideal” Phlebotomy
By Robert Michel | From the Volume XVIII No. 7 – May 23, 2011 Issue
CEO SUMMARY: Lengthy wait times for patients at phlebotomy sites is a common problem for labs across the country. But the laboratory at WellSpan Health System in York, Pennsylvania decided to apply Lean methods to change this situation. Their Lean projects at two pilot patient se…
Why Toronto Is Site of Global Digital Path Center
By Robert Michel | From the Volume XVIII No. 7 – May 23, 2011 Issue
CEO SUMMARY: GE Healthcare and Omnyx chose Canada to be the location of their new Global Pathology Innovation Centre of Excellence (PICOE). PICOE’s mission is to demonstrate that digital pathology can improve patient outcomes in a cost-effective manner. GE and Omnyx will use PI…
Lack of Succession Plan Now Hurts Many Labs
By Robert Michel | From the Volume XVIII No. 5 – April 11, 2011 Issue
CEO SUMMARY: Throughout the past decade, laboratory administrators and pathologists have been reminded about the importance of having a succession plan in their laboratory. Now one veteran lab industry CEO says the lack of a succession plan, unexpected retirements, the d…
Seven Deadly Sins of Lab Management Are Much Too Common
By Robert Michel | From the Volume XVIII No. 5 – April 11, 2011 Issue
CEO SUMMARY: Pity the poor laboratory manager of today. Lab budgets are shrinking. It is difficult to staff adequate numbers of skilled medical technologists. Baby boomers are now retiring. At the same time, accreditation and licensure inspections are becoming tougher. Recently, …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized